<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35288788</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1590-3478</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>43</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title>
          <ISOAbbreviation>Neurol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuromyelitis optica spectrum disorders associated with systemic sclerosis: a case report and literature review.</ArticleTitle>
        <Pagination>
          <StartPage>4015</StartPage>
          <EndPage>4018</EndPage>
          <MedlinePgn>4015-4018</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-05984-2</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bollo</LastName>
            <ForeName>Luca</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-3673-2030</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santoro</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-8585-7753</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Libro</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pellicciari</LastName>
            <ForeName>Roberta</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paolicelli</LastName>
            <ForeName>Damiano</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iaffaldano</LastName>
            <ForeName>Pietro</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trojano</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-6329-8946</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy. maria.trojano@uniba.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Neurol Sci</MedlineTA>
        <NlmUniqueID>100959175</NlmUniqueID>
        <ISSNLinking>1590-1874</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009471" MajorTopicYN="Y">Neuromyelitis Optica</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012595" MajorTopicYN="Y">Scleroderma, Systemic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>5</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35288788</ArticleId>
        <ArticleId IdType="doi">10.1007/s10072-022-05984-2</ArticleId>
        <ArticleId IdType="pii">10.1007/s10072-022-05984-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Deeb K, Eby J, Labault-Santiago J (2019) Demyelinating syndrome in systemic sclerosis and neuromyelitis optica. BMC Neurol 19(1):234</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-019-1472-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wingerchuk DM, Weinshenker BG (2012) The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 18(1):5–10</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1352458511431077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR et al (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350–363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2018.11.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trojanowska M (2010) Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol 6(8):453–460</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrrheum.2010.102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moriguchi K, Kaida K, Togashi N, Onoue H, Ikewaki K (2015) Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies. J Neurol Sci 353(1–2):191–192</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2015.04.027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández ZM, Cohen BA, Derwenskus J (2012) Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis. Mult Scler Relat Disord 1(4):202–203</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2012.04.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franciotta D, Zardini E, Caporali R, Piccolo L, Alberici E, Romani A et al (2011) Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis. J Neurol Sci 303(1–2):139–141</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2011.01.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi M, Nagata R, Ozaki A, Kaneko S, Saiki H, Matsumoto S (2009) A case of anti-AQP4 antibody-positive recurrent myelitis overlapped with autoimmune disorders including incomplete CREST syndrome revealed multiple discontinuous cord lesions. Rinsho Shinkeigaku 49(2–3):115–118</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5692/clinicalneurol.49.115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torabi AM, Patel RK, Wolfe GI, Hughes CS, Mendelsohn DB, Trivedi JR (2004) Transverse myelitis in systemic sclerosis. Arch Neurol 61(1):126–128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.61.1.126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bollo L, Iaffaldano P, Ruggieri M, Palazzo C, Mastrapasqua M, Manni A et al (2021) Longitudinal evaluation of serum MOG-IgG and AQP4-IgG antibodies in NMOSD by a semiquantitative ratiometric method. Front Neurol 12:633115</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2021.633115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.38098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000001729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández ZM, Cohen BA, Derwenskus J (2012) Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis. Mult Scler Relat Disord 1(4):202–203</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2012.04.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106–2112</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(04)17551-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 19(9):14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-9-14</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Yi H, Liu J, Li M, Mao Z-F, Xu L et al (2016) Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders. J Neurol Sci 15(366):3–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2016.04.039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR et al (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350–363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2018.11.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della Rossa A et al (2019) One year in review 2019: systemic sclerosis. Clin Exp Rheumatol Suppl 119(4):3–14</Citation>
        </Reference>
        <Reference>
          <Citation>Huang X, Wu J, Xiao Y, Zhang Y (2021) Timing of plasma exchange for neuromyelitis optica spectrum disorders: a meta-analysis. Mult Scler Relat Disord 48:102709</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2020.102709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao F, Chai B, Gu C, Wu R, Dong T, Yao Y et al (2019) Effectiveness of rituximab in neuromyelitis optica: a meta-analysis. BMC Neurol 19(1):36</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-019-1261-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M et al (2014) Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology 82(15):1302–1306</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000000317</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35288788</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1590-3478</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>43</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title>
          <ISOAbbreviation>Neurol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuromyelitis optica spectrum disorders associated with systemic sclerosis: a case report and literature review.</ArticleTitle>
        <Pagination>
          <StartPage>4015</StartPage>
          <EndPage>4018</EndPage>
          <MedlinePgn>4015-4018</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-05984-2</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bollo</LastName>
            <ForeName>Luca</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-3673-2030</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santoro</LastName>
            <ForeName>Carlo</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-8585-7753</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Libro</LastName>
            <ForeName>Giuseppe</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pellicciari</LastName>
            <ForeName>Roberta</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paolicelli</LastName>
            <ForeName>Damiano</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iaffaldano</LastName>
            <ForeName>Pietro</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trojano</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-6329-8946</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, 70124, Bari, Italy. maria.trojano@uniba.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Neurol Sci</MedlineTA>
        <NlmUniqueID>100959175</NlmUniqueID>
        <ISSNLinking>1590-1874</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009471" MajorTopicYN="Y">Neuromyelitis Optica</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012595" MajorTopicYN="Y">Scleroderma, Systemic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>5</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35288788</ArticleId>
        <ArticleId IdType="doi">10.1007/s10072-022-05984-2</ArticleId>
        <ArticleId IdType="pii">10.1007/s10072-022-05984-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Deeb K, Eby J, Labault-Santiago J (2019) Demyelinating syndrome in systemic sclerosis and neuromyelitis optica. BMC Neurol 19(1):234</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-019-1472-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wingerchuk DM, Weinshenker BG (2012) The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 18(1):5–10</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1352458511431077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR et al (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350–363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2018.11.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trojanowska M (2010) Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol 6(8):453–460</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrrheum.2010.102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moriguchi K, Kaida K, Togashi N, Onoue H, Ikewaki K (2015) Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies. J Neurol Sci 353(1–2):191–192</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2015.04.027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández ZM, Cohen BA, Derwenskus J (2012) Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis. Mult Scler Relat Disord 1(4):202–203</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2012.04.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franciotta D, Zardini E, Caporali R, Piccolo L, Alberici E, Romani A et al (2011) Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis. J Neurol Sci 303(1–2):139–141</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2011.01.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi M, Nagata R, Ozaki A, Kaneko S, Saiki H, Matsumoto S (2009) A case of anti-AQP4 antibody-positive recurrent myelitis overlapped with autoimmune disorders including incomplete CREST syndrome revealed multiple discontinuous cord lesions. Rinsho Shinkeigaku 49(2–3):115–118</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5692/clinicalneurol.49.115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torabi AM, Patel RK, Wolfe GI, Hughes CS, Mendelsohn DB, Trivedi JR (2004) Transverse myelitis in systemic sclerosis. Arch Neurol 61(1):126–128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.61.1.126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bollo L, Iaffaldano P, Ruggieri M, Palazzo C, Mastrapasqua M, Manni A et al (2021) Longitudinal evaluation of serum MOG-IgG and AQP4-IgG antibodies in NMOSD by a semiquantitative ratiometric method. Front Neurol 12:633115</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2021.633115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.38098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000001729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández ZM, Cohen BA, Derwenskus J (2012) Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis. Mult Scler Relat Disord 1(4):202–203</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2012.04.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106–2112</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(04)17551-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 19(9):14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-9-14</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Yi H, Liu J, Li M, Mao Z-F, Xu L et al (2016) Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders. J Neurol Sci 15(366):3–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2016.04.039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR et al (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350–363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2018.11.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della Rossa A et al (2019) One year in review 2019: systemic sclerosis. Clin Exp Rheumatol Suppl 119(4):3–14</Citation>
        </Reference>
        <Reference>
          <Citation>Huang X, Wu J, Xiao Y, Zhang Y (2021) Timing of plasma exchange for neuromyelitis optica spectrum disorders: a meta-analysis. Mult Scler Relat Disord 48:102709</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2020.102709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao F, Chai B, Gu C, Wu R, Dong T, Yao Y et al (2019) Effectiveness of rituximab in neuromyelitis optica: a meta-analysis. BMC Neurol 19(1):36</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-019-1261-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M et al (2014) Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology 82(15):1302–1306</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000000317</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
